Literature DB >> 35999359

CDK5RAP3 acts as a tumour suppressor in gastric cancer through the infiltration and polarization of tumour-associated macrophages.

Jia-Bin Wang1,2,3, You-Xin Gao1,2,3, Yin-Hua Ye1,2,3, Tong-Xing Lin1,2,3, Ping Li1,2,3, Jian-Xian Lin1,2,3, Qi-Yue Chen1,2,3, Long-Long Cao1,2,3, Mi Lin1,2,3, Ru-Hong Tu1,2,3, Ju-Li Lin1,2,3, Ze-Ning Huang1,2,3, Hua-Long Zheng1,2,3, Jian-Wei Xie1,2,3, Chao-Hui Zheng4,5,6, Chang-Ming Huang7,8,9.   

Abstract

We have demonstrated that CDK5RAP3 exerts a tumour suppressor effect in gastric cancer, but its role in regulating tumour-associated macrophages (TAMs) has not yet been reported. Here, we show that CDK5RAP3 is related to the infiltration and polarization of macrophages. It inhibits the polarization of TAMs to M2 macrophages and promotes the polarization of the M1 phenotype. CDK5RAP3 reduces the recruitment of circulating monocytes to infiltrate tumour tissue by inhibiting the CCL2/CCR2 axis in gastric cancer. Blocking CCR2 reduces the growth of xenograft tumours and the infiltration of monocytes. CDK5RAP3 inhibits the nuclear transcription of NF-κB, thereby reducing the secretion of the cytokines IL4 and IL10 and blocking the polarization of M2 macrophages. In addition, the absence of CDK5RAP3 in gastric cancer cells allows macrophages to secrete more MMP2 to promote the epithelial-mesenchymal transition (EMT) process of gastric cancer cells, thereby enhancing the invasion and migration ability. Our results imply that CDK5RAP3 may be involved in the regulation of immune activity in the tumour microenvironment and is expected to become a potential immunotherapy target for gastric cancer.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35999359     DOI: 10.1038/s41417-022-00515-9

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.854


  39 in total

Review 1.  Tumour-educated macrophages promote tumour progression and metastasis.

Authors:  Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer.

Authors:  Yuming Jiang; Jingjing Xie; Weicai Huang; Hao Chen; Sujuan Xi; Zhen Han; Lei Huang; Tian Lin; Li-Ying Zhao; Yan-Feng Hu; Jiang Yu; Shi-Rong Cai; Tuanjie Li; Guoxin Li
Journal:  Cancer Immunol Res       Date:  2019-10-15       Impact factor: 11.151

Review 3.  Tumor-associated macrophages: functional diversity, clinical significance, and open questions.

Authors:  Subhra K Biswas; Paola Allavena; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-05-09       Impact factor: 9.623

4.  The tumor microenvironment controls drug sensitivity.

Authors:  Arne Ostman
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

6.  Imaging the recruitment of cancer-associated fibroblasts by liver-metastatic colon cancer.

Authors:  Atsushi Suetsugu; Yosuke Osawa; Masahito Nagaki; Shigetoyo Saji; Hisataka Moriwaki; Michael Bouvet; Robert M Hoffman
Journal:  J Cell Biochem       Date:  2011-03       Impact factor: 4.429

7.  Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007).

Authors:  Hitoshi Katai; Takashi Ishikawa; Kohei Akazawa; Yoh Isobe; Isao Miyashiro; Ichiro Oda; Shunichi Tsujitani; Hiroyuki Ono; Satoshi Tanabe; Takeo Fukagawa; Souya Nunobe; Yoshihiro Kakeji; Atsushi Nashimoto
Journal:  Gastric Cancer       Date:  2017-04-17       Impact factor: 7.370

Review 8.  Gastric cancer: a comprehensive review of current and future treatment strategies.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Maria Diab; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2020-09-07       Impact factor: 9.264

Review 9.  The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.

Authors:  L Bingle; N J Brown; Claire E Lewis
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

Review 10.  Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer.

Authors:  Daniela Cornelia Lazăr; Mihaela Flavia Avram; Ioan Romoșan; Mărioara Cornianu; Sorina Tăban; Adrian Goldiș
Journal:  World J Gastroenterol       Date:  2018-08-28       Impact factor: 5.742

View more
  1 in total

Review 1.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.